ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Zyus Life Sciences Corporation

Zyus Life Sciences Corporation (ZYUS)

0.85
0.00
(0.00%)
Closed December 25 4:00PM
Advanced chart
Rendering Error

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.85
Bid
0.82
Ask
0.87
Volume
-
0.00 Day's Range 0.00
0.70 52 Week Range 1.19
Market Cap
Previous Close
0.85
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
3,488
Shares Outstanding
70,847,000
Dividend Yield
-
PE Ratio
-1.41
Earnings Per Share (EPS)
-0.6
Revenue
351k
Net Profit
-42.59M

About Zyus Life Sciences Corporation

Sector
Pharmaceutical Preparations
Industry
Oil And Gas Field Expl Svcs
Website
Headquarters
Toronto, Ontario, Can
Founded
2023
Zyus Life Sciences Corporation is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker ZYUS. The last closing price for Zyus Life Sciences was $0.85. Over the last year, Zyus Life Sciences shares have traded in a share price range of $ 0.70 to $ 1.19.

Zyus Life Sciences currently has 70,847,000 shares outstanding. The market capitalization of Zyus Life Sciences is $60.22 million. Zyus Life Sciences has a price to earnings ratio (PE ratio) of -1.41.

ZYUS Latest News

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSXV: ZYUS) is pleased to announce that Brent Zettl, President and CEO of ZYUS, will present and host one-on-one meetings with investors...

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Receives Patent from United States Patent and Trademark Office (“USPTO”) Supporting ZYUS’ Lead Drug Candidate ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

Dr. Clarke Joins ZYUS’ Clinical Advisory Committee, Bringing Extensive Expertise in Healthcare and Pain Management ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS’ experienced team ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life...

TSX Venture Exchange Stock Maintenance Bulletins

TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, Dec. 28, 2023 VANCOUVER, BC, Dec. 28, 2023 /CNW/ - TSX VENTURE COMPANIES BULLETIN V2023-0415 DRYDEN GOLD CORP...

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

Evaluating Efficacy, Safety, and Tolerability in Patients with Moderate to Severe Cancer-Related Pain ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...

ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

Completion of Phase 1 and Supportive Preclinical Data Will Assist in Ongoing Phase 2 Clinical Development of ZYUS’ Lead Drug Product Candidate ZYUS Life Sciences Corporation ("ZYUS" or the...

ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

Mr. Miller brings nearly two decades of knowledge, experience and expertise to ZYUS ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company...

ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.05-5.555555555560.90.90.7254300.83336206CS
4-0.02-2.298850574710.8710.7237830.8775691CS
120.011.190476190480.8410.734880.82518235CS
26-0.16-15.84158415841.011.050.739380.87642394CS
52-0.05-5.555555555560.91.190.755620.95405692CS
156-1.65-662.52.50.790851.10014093CS
260-1.65-662.52.50.790851.10014093CS

ZYUS - Frequently Asked Questions (FAQ)

What is the current Zyus Life Sciences share price?
The current share price of Zyus Life Sciences is $ 0.85
How many Zyus Life Sciences shares are in issue?
Zyus Life Sciences has 70,847,000 shares in issue
What is the market cap of Zyus Life Sciences?
The market capitalisation of Zyus Life Sciences is CAD 60.22M
What is the 1 year trading range for Zyus Life Sciences share price?
Zyus Life Sciences has traded in the range of $ 0.70 to $ 1.19 during the past year
What is the PE ratio of Zyus Life Sciences?
The price to earnings ratio of Zyus Life Sciences is -1.41
What is the cash to sales ratio of Zyus Life Sciences?
The cash to sales ratio of Zyus Life Sciences is 170
What is the reporting currency for Zyus Life Sciences?
Zyus Life Sciences reports financial results in CAD
What is the latest annual turnover for Zyus Life Sciences?
The latest annual turnover of Zyus Life Sciences is CAD 351k
What is the latest annual profit for Zyus Life Sciences?
The latest annual profit of Zyus Life Sciences is CAD -42.59M
What is the registered address of Zyus Life Sciences?
The registered address for Zyus Life Sciences is 3400-22 ADELAIDE STREET W, TORONTO, ONTARIO, M5H 4E3
What is the Zyus Life Sciences website address?
The website address for Zyus Life Sciences is www.zyus.com
Which industry sector does Zyus Life Sciences operate in?
Zyus Life Sciences operates in the OIL AND GAS FIELD EXPL SVCS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
TVITVI Pacific Inc
$ 0.005
(-50.00%)
2k
CCDCascadero Copper Corporation
$ 0.005
(-50.00%)
1.56k
KGL.HKGL Resources Ltd
$ 0.03
(-40.00%)
5.5k
SAFSeasif Exploration Inc
$ 0.025
(-37.50%)
61k
AAZAzincourt Energy Corp
$ 0.01
(-33.33%)
110.54k
CPLCopper Lake Resources Ltd
$ 0.01
(0.00%)
11.98M
WCUWorld Copper Ltd
$ 0.05
(-23.08%)
5.75M
QNCQuantum Emotion Corp
$ 0.66
(24.53%)
4.89M
THRMTherma Bright Inc
$ 0.035
(16.67%)
2.64M
CANSWildpack Beverage Inc
$ 0.01
(100.00%)
2.12M

ZYUS Financials

Financials
Rendering Error

Discussion

View Full Feed
StayHumble StayHumble 7 minutes ago
Long Story Short💹Andrew's Cooked,Kramers Left Right?💹wow


https://www.sec.gov/enforcement-litigation/litigation-releases/lr-25995
https://media1.tenor.com/m/3ZlZAoAZ8BgAAAAC/thriller-mj.gif
DBMM
badog badog 7 minutes ago
Doesn't matter. My life history or employment history will not change ERHC's future. You are looking for something to critique.

Again...you priorities are all messed up. If you want to criticize anyone it should be posters who keep putting out scenarios that never can be ver
ERHE
Iggy_Bot Iggy_Bot 9 minutes ago
Ok GS, Christmas is over ' Let's get this train a rolling: https://www.youtube.com/watch?v=1SX1fvt-a5g
WNFT
nowwhat2 nowwhat2 11 minutes ago
https://ih.advfn.com/stock-market/COIN/XRPUSD/crypto-news/95154727/xrp-whales-keep-buying-data-reveals-smart-money


https://investorshub.advfn.com/uimage/uploads/2024/12/25/qn[ffxrp_121212_25_15d_7am_CHAN_OF_DESTINY.jpg






XRPUSD
kund kund 11 minutes ago
There are many posts speculating about when the EMA approval will come. Consider yourself lucky if you hear any decision by H2 2026. EMA and Misleading seem like a match made in heaven—both will drag this out to the very end.
AVXL
fuagf fuagf 11 minutes ago
Me too. Tired (four hours sleep just now) of sidewalks, though they offer decent exercise.

"The main difference between Tesla Autopilot and Full Self-Driving (FSD) is
that Autopilot is a partial automation system, while FSD is semi-autonomous: "

And it is go
DeerBalls DeerBalls 12 minutes ago
$.00765 So, where are we? This is how I see it:

We will see a service of one or both of the anti-trust/class-action, anti-trust cases soon. I think VPLM has until about the 25th of Jan. to serve, but won't wait near that long. If we don't see service soon, that would indicate to m
VPLM
StayHumble StayHumble 12 minutes ago
on X right?💹"$UBQU isn't planning a ReverseSplit💹IO Merger instead"
https://x.com/CorporateUbqu/status/1765510100628726105?s=20
https://investorshub.advfn.com/uimage/uploads/2024/12/21/hiinwubqu.png
"trust me bro i'm an insider too"
https://cdn.vox-cdn.co
UBQU
baltimorebullet baltimorebullet 14 minutes ago
But doesn't it perhaps also explain why his trial design and execution were not as impressive?
AVXL
dstock07734 dstock07734 16 minutes ago
mate,

What brings you back? Recall last time you let your lawyer write the reply. That's really funny. Hope the following figure can jog your memory.

I suspect this time your agenda is different from the one in April. This time you see $NWBO as an enormous opportunity
NWBO
Iggy_Bot Iggy_Bot 17 minutes ago
Meaning, they don't like Trump so if they can't be with the one they love, love the one your with.. all a game
StayHumble StayHumble 17 minutes ago
"I ShortNaked🔥24/7" tops the list per X MorganStanleyEmployee
“Gaming Wall Street”- HBO Documentary


Ex Morgan Stanley employee explains the situation about shorting and naked shorting perfectly!


Again, this is a MUST WATCH video fo
xodcode xodcode 17 minutes ago
Blessings to all and your loved ones this holiday season.
Looks like 2025 could be a wonderful year for AVXL longs, as according to ChatGPT, odds of blarcamasine EMA approval are somewhere around 90%. According to ChatGPT:
"The European Medicines Agency (EMA) has a high approval rate f
AVXL
StayHumble StayHumble 18 minutes ago
💹11M BUYS💹+ High Sell Orders💹$9.9991 wow https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3
MJNA
Zorax Zorax 18 minutes ago
Anyone notice the older you get the later in the day you wake up to enjoy festivities.
Student of the Game Student of the Game 19 minutes ago
Merry Christmas and Happy Chanukah to all!!

A very Healthy and Peaceful New year!!
CUBT
Investor2014 Investor2014 20 minutes ago
I agree with your apparently arrogant opinion based on fact.
AVXL
abazaba375 abazaba375 22 minutes ago
Record volume day trading 60 % of the OS boom coming 
BANT
carlson carlson 23 minutes ago
Give us PEACE on Christmas PLEASE!!!!!!!!!
NBRI
Ecomike Ecomike 24 minutes ago
Hogwash mixed with 100% Malarkey, based on total BS.
NFTM
Jimmy Joe Jimmy Joe 24 minutes ago
Anyway, Merry Christmas and GO TRUMP...(Happy New Year and GO TRUMP are synonymous)

Yeah, he's gonna fix everything and take our rights away. Living in Russia will be wonderful.
4 years of stupidity again. Let's drink some bleach and toast the Trumpy Bear commercials in.
ELTP
Lime Time Lime Time 24 minutes ago
Rescind the reverse stock split plans, then everyone will turn positive. As long as that's still on the plate, there is no reason to buy this. Waiting... and time is running out.
MIKP
Ecomike Ecomike 27 minutes ago
It was not rejected. SEC asked them to withdraw it, make changes and refile. Likely, IMO, because there was nothing on the Form 10 about Prodigy.
Yet.... That was because Prodigy had not been bought yet, as of the closing date of the annual audits in the original Form 10.

Then
CNNA

Your Recent History

Delayed Upgrade Clock